A Strep A vaccine global demand and return on investment forecast to inform industry research and development prioritization
Abstrak
Abstract Investment in Strep A vaccine R&D is disproportionately low relative to the large burden of Strep A diseases globally. This study presents a novel Strep A vaccine global demand and financial forecast model with estimates of potential global demand and associated revenue and profits for a hypothetical Strep A vaccine as well as a net present value (NPV) analysis of return on capital investments required to develop the vaccine. A positive NPV was calculated for a variety of developer scenarios and target populations, including the global rollout of the vaccine in private and public markets by a multinational pharmaceutical corporation and a staged rollout by a developing country vaccine manufacturer for both infant and child populations. The results suggest there is a viable commercial market for a Strep A vaccine. It is hoped that this study will help to inform industry decision-making and drive increased prioritization of, and investment in, Strep A vaccine research and development.
Topik & Kata Kunci
Penulis (7)
Donald R. Walkinshaw
Meghan E. E. Wright
Marni Williams
Tanya M. F. Scarapicchia
Jean-Louis Excler
Ryan E. Wiley
Anne E. Mullin
Format Sitasi
Akses Cepat
- Tahun Terbit
- 2023
- Sumber Database
- DOAJ
- DOI
- 10.1038/s41541-023-00690-2
- Akses
- Open Access ✓